Home » Topics » BioWorld Science

BioWorld Science
RSS

Animal study indicates potential of GAT inhibitors for anxiety

Dec. 18, 1997

AEterna's psoriasis agent moves to phase I/II in Canada

Dec. 18, 1997

Behavioral effects of novel mGluR agonist in rats

Dec. 18, 1997

Italian launch for Alzheimer's disease treatment

Dec. 18, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

Daiichi's Floxin receives FDA approval

Dec. 18, 1997

Genzyme General seeks U.S. and European approval for Thyrogen

Dec. 18, 1997

Naratriptan acts through 5-HT1B/1D receptors and accesses the CNS

Dec. 18, 1997

Pentose receives U.S. and European patent allowances for Papirine compounds

Dec. 18, 1997

Verapamil derivative from Toa Eiyo with potential in supraventricular tachycardia

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...